Evidence map›Paper›PMID 42397450›Full record

ArticleMolecular biology reports2026

Molecular characterization and genotypic diversity of extensively drug-resistant Acinetobacter baumannii from endotracheal aspirates in a pediatric intensive care unit in Sulaimani, Iraq.

Seenaa Mohammed Ali

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Seenaa Mohammed AliDepartment of Medical Laboratory, College of Health and Medical Technology, Sulaimani Polytechnic University, Sulaymaniyah, Kurdistan Region, Iraq. seenaa.ali@spu.edu.iq.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundExtensively drug-resistant (XDR) Acinetobacter baumannii poses a significant threat in pediatric intensive care units (PICUs), particularly in regions with limited surveillance data. This study characterized the bacterial profile of endotracheal aspirate samples from a PICU in Sulaimani, confirmed A. baumannii identification using bla METHODS AND

resultsFrom August 2023 to March 2025, 100 consecutive Gram-negative isolates were recovered from mechanically ventilated pediatric patients. VITEK2 was used for identification and susceptibility testing. XDR Acinetobacter isolates underwent molecular confirmation via bla

conclusionsThis study provides the first molecular epidemiological characterization of XDR A. baumannii in an Iraqi PICU, revealing clonal persistence of a successful epidemic strain and critical gaps in phenotypic identification. These findings emphasize the need for routine molecular surveillance, targeted infection control, and antimicrobial stewardship in resource-limited settings.

Indexed as

Acinetobacter baumanniiAcinetobacter InfectionsDrug Resistance, Multiple, BacterialAnti-Bacterial Agentsbeta-LactamasesChildChild, PreschoolFemaleGenetic VariationGenotypeHumansInfantIntensive Care Units, PediatricIraqMaleMicrobial Sensitivity TestsAnti-Bacterial Agentsbeta-LactamasesAcinetobacter baumanniibla OXA−51endotracheal aspirateERIC-PCRpediatric intensive care

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.